Ultrasound for Postop Lung Issues in Low-Flow Anesthesia
NCT ID: NCT06824506
Last Updated: 2025-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
110 participants
OBSERVATIONAL
2025-02-15
2026-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lung Ultrasound, Cholecystectomy, Atelectasis
NCT06664658
Effect of Recruitment Maneuver on Postoperative Atelectasis Assessed by Lung Ultrasound in Laparoscopic Cholecystectomy
NCT07324122
Diaphragmatic Excursion Changes and Postoperative Oxygenation After Laparoscopic Cholecystectomy
NCT07332728
Ultrasound Assessment of Airway Edema During Laparoscopic Cholecystectomy
NCT07021482
The Effect of Preoxygenation on Gastric Decompression in Laparoscopic Cholecystectomies
NCT07274488
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Lung ultrasonography (Lung USG) draws attention for the rapid, cheap, safe and reliable detection of postoperative atelectasis. The fact that it can be applied at the bedside and can be easily repeated makes this method valuable. In the literature and in daily practice, it is seen that anesthesiologists commonly apply inhalation anesthesia with different fresh gas flow (FGF) rates during general anesthesia.
As defined by Baker and Simionescu, in low-flow anesthesia, FGF varies between 0.5 and 1 liter per minute. It has been shown that all types of flow are safe with modern anesthesia machines.
This study aims to demonstrate the effect of low-flow anesthesia (LFA) on pulmonary complications and, in particular, atelectasis that may develop after laparoscopic cholecystectomy operations, using a non-invasive, rapidly applicable, and proven method such as Lung USG.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low-Flow Anesthesia Group
As this study is observational in nature, no interventions will be performed by the research team. The study will involve a single group, within which the incidence and prevalence of the outcomes will be assessed.
No-intervention
No interventions will be performed by the research team.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No-intervention
No interventions will be performed by the research team.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients scheduled for laparoscopic cholecystectomy
* Patients with a Body Mass Index between 18-35 kg/m²
* Patients in the American Society of Anesthesiologist (ASA) 1-2-3 category
Exclusion Criteria
* Patients with ASA 4 and above
* Patients with lung disease
* Patients who have undergone thoracic surgery
* Pregnancy
* Patients with a preoperative Lung Ultrasound Score of 2 or 3 in any lung region
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara Ataturk Sanatorium Training and Research Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mustafa Özgür Cirik
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mustafa Özgür CIRIK, MD
Role: PRINCIPAL_INVESTIGATOR
Ankara Ataturk Sanatorium Training and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara Ataturk Sanatorium Research and Training Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Necla DERELI, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SanatoryumEAH-AK-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.